Paradoxical Effect of Colchicine on Urine Monocyte Chemoattractant Protein 1: Results from an Exploratory Randomized Controlled Trial
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Mansour S, Puthumana J, Coca S, Gentry M, Parikh C
. Biomarkers for the detection of renal fibrosis and prediction of renal outcomes: a systematic review. BMC Nephrol. 2017; 18(1):72.
PMC: 5319065.
DOI: 10.1186/s12882-017-0490-0.
View
2.
Li J, Lee S, Kim D, Jin R, Jung D, Kwak S
. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy. Am J Physiol Renal Physiol. 2009; 297(1):F200-9.
DOI: 10.1152/ajprenal.90649.2008.
View
3.
Guan T, Gao B, Chen G, Chen X, Janssen M, Uttarwar L
. Colchicine attenuates renal injury in a model of hypertensive chronic kidney disease. Am J Physiol Renal Physiol. 2013; 305(10):F1466-76.
DOI: 10.1152/ajprenal.00057.2013.
View
4.
Wason S, Mount D, Faulkner R
. Single-dose, open-label study of the differences in pharmacokinetics of colchicine in subjects with renal impairment, including end-stage renal disease. Clin Drug Investig. 2014; 34(12):845-55.
DOI: 10.1007/s40261-014-0238-6.
View
5.
El-Rashid M, Nguyen-Ngo D, Minhas N, Meijles D, Li J, Ghimire K
. Repurposing of metformin and colchicine reveals differential modulation of acute and chronic kidney injury. Sci Rep. 2020; 10(1):21968.
PMC: 7738483.
DOI: 10.1038/s41598-020-78936-5.
View